CD4 and COVID-19: In naïve individuals, this booster significantly increased the levels of spike-specific antibodies and B and CD4+ T cells, while in recovered COVID-19 individuals, the booster dose has minor effects (230), in line with what was observed for the second vaccine dose (249, 250).